Director, Global Medical Affairs, Sjogren's Disease
05/10/2026,
Bristol-Myers Squibb Company
Princeton, NJ
Medical Affairs
Medical Science Liaison, Cell Therapy Autoimmune (CTAI) - Florida
05/10/2026,
Bristol-Myers Squibb Company
Orlando, FL
Medical Affairs
Medical Science Liaison, Cell Therapy Autoimmune (CTAI) - (IN, OH, KY, W. PA)
05/10/2026,
Bristol-Myers Squibb Company
Cleveland, OH
Medical Affairs
Medical Science Liaison, Camzyos (PA)
05/10/2026,
Bristol-Myers Squibb Company
Pittsburgh, PA
Medical Affairs
Medical Science Liaison, Cell Therapy Autoimmune (CTAI) - (N. CA, NV, UT, AZ)
05/09/2026,
Bristol-Myers Squibb Company
San Francisco, CA
Medical Affairs
Medical Science Liaison, Cell Therapy Autoimmune (CTAI) - (NM, N. TX, OK)
05/09/2026,
Bristol-Myers Squibb Company
Dallas, TX
Medical Affairs
Medical Science Liaison, Cell Therapy Autoimmune (CTAI) - (CO, NE, KS, MO, IA, MN)
05/09/2026,
Bristol-Myers Squibb Company
Denver, CO
Medical Affairs
Medical Science Liaison, Cell Therapy Autoimmune (CTAI) - (S. TX, LA, AR, TN)
05/09/2026,
Bristol-Myers Squibb Company
Houston, TX
Medical Affairs
Medical Science Liaison, Cell Therapy Autoimmune (CTAI) - (WI, IL, MI)
05/09/2026,
Bristol-Myers Squibb Company
Chicago, IL
Medical Affairs